摘要
目的:本研究旨在研究淀粉样蛋白(Aβ)诱导人视网膜色素上皮细胞系(ARPE-19)细胞产生血管生成因子的机制。 方法:本研究采用美国典型培养物保藏中心(ATCC)获得的ARPE-19细胞。 通过实时定量PCR(RT-PCR)测量血管内皮生长因子(VEGF),白细胞介素-8(IL-8),单核细胞趋化蛋白-1(MCP-1)和补体活化片段C3a和C5a的表达水平和酶联免疫吸附测定(ELISA)。运用流式细胞术测量线粒体相关活性氧(ROS)的产生。 结果:Aβ治疗ARPE-19细胞中VEGF,IL-8,MCP-1,C3a和C5a的表达显着增加。线粒体相关的ROS当暴露于Aβ时,其产生也显着增加。用二苯基碘化铵(DPI)抑制线粒体ROS显着降低了ARPE-19细胞对Aβ诱导的VEGF,IL-8,MCP-1,C3a和C5a的产生。抗AβC3a或抗-C5a中和抗体在用Aβ刺激时对ARPE-19细胞的VEGF,IL-8和MCP-1的分泌没有可检测的影响。 结论:我们的结果支持Aβ通过RPE细胞促进血管生成细胞因子VEGF,IL-8和MCP-1的产生参与脉络膜新血管形成(CNV)发病机制的假说。显示线粒体ROS在调节Aβ诱导的这些细胞因子的表达中起作用。
关键词: 淀粉样蛋白β,玻璃疣,脉络膜新血管形成,视网膜色素上皮,年龄相关性黄斑变性,线粒体相关活性氧。
Current Molecular Medicine
Title:The Role of Mitochondria-Associated Reactive Oxygen Species in the Amyloid β Induced Production of Angiogenic Factors b y ARPE-19 Cells
Volume: 17 Issue: 2
关键词: 淀粉样蛋白β,玻璃疣,脉络膜新血管形成,视网膜色素上皮,年龄相关性黄斑变性,线粒体相关活性氧。
摘要: Objective: This study aimed to investigate the mechanisms whereby Amyloidbeta (Aβ) induces the production of angiogenic factors by a human retinal pigment epithelial cell line (ARPE-19) cells.
Methods: ARPE-19 cells obtained from the American Type Culture Collection (ATCC) were utilized in this study. The expression level of vascular endothelial growth factor (VEGF), Interleukin-8 (IL-8), monocyte chemoattractant protein-1 (MCP-1) and complement activation fragments C3a and C5a were measured by Real-time quantitative PCR (RT-PCR) and Enzyme-linked immunosorbent assay (ELISA). The production of mitochondria-associated reactive oxygen species (ROS) was measured by flow cytometry. Results: The expression of VEGF, IL-8, MCP-1, C3a and C5a was significantly increased in Aβ-treated ARPE-19 cells. Mitochondria-associated ROS production was also significantly increased when exposed to Aβ. Inhibition of mitochondrial ROS with Diphenyleneiodonium chloride (DPI) markedly decreased the Aβ induced production of VEGF, IL-8, MCP-1, C3a and C5a by ARPE-19 cells. Anti-C3a or anti-C5a neutralizing antibodies did not have a detectable influence on the secretion of VEGF, IL-8 and MCP-1 by ARPE-19 cells upon stimulation with Aβ. Conclusion: Our results support the hypothesis that Aβ is involved in the pathogenesis of choroidal neovascularization (CNV) formation by promoting the production of the angiogenic cytokines VEGF, IL-8 and MCP-1 by RPE cells. Mitochondrial ROS was shown to play a role in the regulation of Aβ induced expression of these cytokines.Export Options
About this article
Cite this article as:
The Role of Mitochondria-Associated Reactive Oxygen Species in the Amyloid β Induced Production of Angiogenic Factors b y ARPE-19 Cells, Current Molecular Medicine 2017; 17 (2) . https://dx.doi.org/10.2174/1566524017666170331162616
DOI https://dx.doi.org/10.2174/1566524017666170331162616 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Chemical Modifications of Ketoprofen (NSAID) in Search of Better Lead Compounds: A Review of Literature From 2004-2016
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Classical to Current Approach for Treatment of Psoriasis: A Review
Endocrine, Metabolic & Immune Disorders - Drug Targets Thalidomide Derived Immunomodulatory Drugs (IMiDs) as Potential Therapeutic Agents
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Protective Effect of Zinc on Mouse Renal Ischemia-reperfusion Injury by Anti-apoptosis and Antioxidation
Current Pharmaceutical Biotechnology Diabetic Neuropathy: Update on Pathophysiological Mechanism and the Possible Involvement of Glutamate Pathways
Current Diabetes Reviews Involvement of Immune Response in the Pathogenesis of Amyotrophic Lateral Sclerosis: A Therapeutic Opportunity?
CNS & Neurological Disorders - Drug Targets Neuroinflammation and Neuroprotective Strategies in Acute Ischaemic Stroke - from bench to bedside
Current Molecular Medicine Editorial (Hot Topic: Treatment of Atherosclerosis as an Inflammatory Disease)
Current Pharmaceutical Design Editorial (Thematic Issue: Angiogenesis in the Development of Cardiovascular Diseases)
Current Angiogenesis (Discontinued) Immunotoxicity, Flow Cytometry, and Chemoinformatics: Review, Bibliometric Analysis, and New QSAR Model of Drug Effects Over Macrophages
Current Topics in Medicinal Chemistry Epigenetic Mechanisms and Kidney Diseases
Current Medicinal Chemistry Purine Nucleoside Phosphorylase: A Potential Target for the Development of Drugs to Treat T-Cell- and Apicomplexan Parasite-Mediated Diseases
Current Drug Targets Anti-Inflammatory and Anti-Oxidant Activity of a New Class of Phenyl- Pyrazolone Derivatives
Current Drug Discovery Technologies Her2/neu Small Interfering RNA Delivered in Culture by a Streptavidin Nanoparticle
Current Drug Delivery Multiple Sclerosis – Established and Novel Therapeutic Approaches
Central Nervous System Agents in Medicinal Chemistry New Costimulatory Families: Signaling Lymphocytic Activation Molecule in Adaptive Allergic Responses
Current Molecular Medicine Ascorbic Acid in Cancer Chemoprevention: Translational Perspectives and Efficacy
Current Drug Targets Mechanisms Linking Leptin to Arterial and Venous Thrombosis: Potential Pharmacological Targets
Current Pharmaceutical Design Clinical Application of Ropivacaine for the Lower Extremity
Current Topics in Medicinal Chemistry New Directions for Half-Life Extension of Protein Therapeutics: The Rise of Antibody Fc Domains and Fragments
Current Pharmaceutical Biotechnology